CD24 Contributes to Treatment Effect in ABC-DLBCL Patients with R-CHOP Resistance

PURPOSE: Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin’s lymphoma and of which the prognosis of activated B-cell-like (ABC) subtype is poor. Although R-CHOP significantly improves the survival of patients with DLBCL, 20% to 40% of patients were resistant to R-CHOP therapy. Thu...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Li-Yan, Li, Han-Bing, Zhang, Yue, Shen, Di, Liu, Peng, Che, Yi-Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165940/
https://www.ncbi.nlm.nih.gov/pubmed/34079334
http://dx.doi.org/10.2147/PGPM.S310816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165940/
https://www.ncbi.nlm.nih.gov/pubmed/34079334
http://dx.doi.org/10.2147/PGPM.S310816

Ejemplares similares